Literature DB >> 9884822

Cytopathology of high-grade papillary thyroid carcinomas: tall-cell variant, diffuse sclerosing variant, and poorly differentiated papillary carcinoma.

N P Ohori1, K E Schoedel.   

Abstract

Cytologic reports of the aggressive tall-cell and diffuse sclerosing variants of papillary carcinoma have emphasized features such as tall and large cells, increased nuclear size, nuclear pleomorphism, intranuclear pseudoinclusions, three-dimensional tissue fragments, squamous-like cells, and dense inflammatory background as characteristic features. However, the specificity of these features in identifying the particular variants and distinguishing them from other poorly differentiated papillary carcinomas and typical low-grade forms of papillary carcinoma has not been established. The objective of this study was to assess the predictive value of these reported cytologic features. Fourteen cases of high-grade papillary carcinoma consisting of the aggressive variants (tall-cell variant (tcv) and diffuse sclerosing variant (dsv)) and poorly differentiated papillary carcinomas (pdpc) were compared to 18 cases of low-grade papillary carcinoma. Seven cytologic features consisting of the presence of tall and large cells, architectural disorganization, nuclear enlargement, prominent intranuclear pseudoinclusions, nuclear pleomorphism, lymphocytic infiltrate, and squamoid appearance of the neoplastic cells were evaluated. Cytology samples from tcv, dsv, and pdpc consistently demonstrated 3 of the 7 cytologic features (architectural disorganization, nuclear enlargement, and pleomorphism). In contrast, only two of the samples from low-grade cases demonstrated these 3 features. The recognition of these 3 cytologic features had a positive predictive value of 88% and a negative predictive value of 100% for identifying tcv, dsv, and pdpc. The remaining cytologic features were not a consistent feature in the variants, and by cytology alone, distinction between the aggressive variants (dsv and tcv) and pdpc could not be made.

Entities:  

Mesh:

Year:  1999        PMID: 9884822     DOI: 10.1002/(sici)1097-0339(199901)20:1<19::aid-dc5>3.0.co;2-r

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  6 in total

1.  Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Authors:  Lester D R Thompson; Jacqueline A Wieneke; Clara S Heffess
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Role of fine-needle aspiration biopsy and frozen section in the management of papillary thyroid carcinoma subtypes.

Authors:  Julio C Furlan; Yvan C Bedard; Irving B Rosen
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

3.  Cribriform morular variant of papillary thyroid carcinoma: Cytomorphology, differential diagnosis and diagnostic implications in patients with adenomatous polyposis coli.

Authors:  Amarathunga Ah Priyani; Shamika T Opatha; Nisayuri W Gunathilake; Menaka Ds Lokuhetty
Journal:  J Cytol       Date:  2016 Oct-Dec       Impact factor: 1.000

4.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

Review 5.  Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer?

Authors:  Tobias Carling; Idris T Ocal; Robert Udelsman
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

6.  Fine-needle aspiration of the thyroid: an overview.

Authors:  Gia-Khanh Nguyen; Mark W Lee; Jody Ginsberg; Tina Wragg; Darcy Bilodeau
Journal:  Cytojournal       Date:  2005-06-29       Impact factor: 2.091

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.